Insider Trading activities of Angiodynamics Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Angiodynamics Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Angiodynamics Inc since year 2005. Table 2 shows the detailed insider transactions of Angiodynamics Inc since 2005. The reporting company's ticker symbol is ANGO. The reporting company's CIK number is 1275187.
The total value of stock buying since 2005 is $2,612,816.
The total value of stock sales since 2005 is $223,825,707.
The total value of stock option exercises since 2005 is $10,784,391.


 1   2 
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Angiodynamics Inc (ANGO).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-11 0 $0 27,409 $446,492 41,409 $498,456
2017-07 30,316 $475,406 0 $0 42,000 $661,500
2017-06 0 $0 0 $0 14,000 $220,500
2017-04 0 $0 4,700,000 $75,200,000 0 $0
2017-01 0 $0 0 $0 14,000 $220,500
2016-11 0 $0 4,182,588 $65,582,978 0 $0
2016-08 0 $0 4,491,000 $65,658,420 24,000 $318,960
2016-07 0 $0 0 $0 40,576 $478,440
2016-05 0 $0 3,508 $43,183 0 $0
2016-04 0 $0 12,940 $159,184 0 $0
2015-08 0 $0 0 $0 43,900 $670,353
2015-07 0 $0 0 $0 6,000 $91,620
2015-06 0 $0 0 $0 4,649 $76,940
2015-02 0 $0 18,100 $335,393 18,100 $276,387
2014-10 0 $0 3,298 $51,547 0 $0
2014-07 0 $0 0 $0 6,000 $79,080
2014-04 1,000 $13,900 0 $0 15,500 $170,500
2013-11 0 $0 6,765 $104,451 4,373 $57,636
2013-10 5,000 $75,990 20,000 $301,200 20,000 $220,000
2013-07 2,700 $32,400 0 $0 0 $0
2013-05 0 $0 1,495 $15,518 0 $0
2013-03 89,600 $966,072 0 $0 2,508 $16,357
2013-02 2,000 $24,332 0 $0 0 $0
2013-01 2,700 $31,276 0 $0 0 $0
2012-11 1,000 $10,560 3,160 $32,737 0 $0
2012-07 2,000 $23,340 0 $0 0 $0
2012-05 0 $0 2,080 $25,827 0 $0
2012-04 14,700 $173,003 0 $0 2,509 $16,363
2012-02 8,000 $105,149 0 $0 0 $0
2011-11 2,500 $35,362 0 $0 0 $0
2011-09 0 $0 0 $0 3,000 $40,470
2011-08 6,000 $84,168 0 $0 5,000 $55,000
2011-06 0 $0 0 $0 2,091 $9,091
2010-10 1,500 $21,429 0 $0 0 $0
2010-09 0 $0 0 $0 6,500 $98,994
2010-08 0 $0 0 $0 3,750 $0
2010-07 500 $7,347 0 $0 0 $0
2010-04 500 $7,760 0 $0 2,091 $9,091
2010-02 4,500 $71,417 0 $0 0 $0
2009-07 9,000 $102,096 0 $0 0 $0
2009-05 0 $0 0 $0 2,091 $9,091
2009-04 7,000 $86,330 0 $0 0 $0
2009-02 5,000 $65,000 15,000 $194,775 7,267 $60,348
2009-01 8,426 $105,208 0 $0 0 $0
2008-08 1,000 $15,920 0 $0 0 $0
2008-05 1,300 $19,666 0 $0 0 $0
2008-04 2,715 $35,205 0 $0 0 $0
2008-03 0 $0 0 $0 2,000 $22,000
2007-08 0 $0 5,100 $105,253 5,100 $67,218
2007-05 0 $0 0 $0 2,891 $36,781
2007-04 0 $0 0 $0 1,000 $13,180
2007-03 0 $0 0 $0 8,364 $36,358
2007-01 1,000 $24,480 3,455 $86,375 84,364 $383,361
2006-12 0 $0 0 $0 278,318 $4,164,192
2006-11 0 $0 15,082 $318,595 4,082 $17,744
2006-10 0 $0 26,000 $559,568 19,287 $78,899
2006-09 0 $0 26,000 $520,098 29,600 $133,671
2006-08 0 $0 21,000 $442,131 42,000 $198,060
2006-07 0 $0 57,500 $1,455,915 20,000 $86,940
2006-06 0 $0 20,000 $551,140 20,000 $86,940
2006-05 0 $0 35,281 $1,047,644 81,085 $359,807
2006-04 0 $0 35,000 $1,011,915 35,000 $152,144
2006-03 0 $0 130,162 $3,626,833 67,000 $319,244
2006-02 0 $0 24,200 $652,503 33,100 $143,909
2006-01 0 $0 52,338 $1,419,652 29,500 $128,266
2005-12 0 $0 6,496 $156,522 0 $0
2005-11 0 $0 12,759 $278,132 0 $0
2005-10 0 $0 6,496 $134,921 0 $0
2005-09 0 $0 6,496 $146,532 0 $0
2005-08 0 $0 8,120 $182,330 0 $0
2005-07 0 $0 67,216 $1,613,470 0 $0
2005-06 0 $0 22,060 $464,001 0 $0
2005-05 0 $0 36,249 $710,372 0 $0
2005-04 0 $0 10,000 $190,100 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Angiodynamics Inc insiders (ANGO)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-11-21 Donnelly Howard W Option Ex 14,000 13.53 189,420
2017-11-15 Richard Stark (SVP, GM - Oncology) Sale 27,409 16.29 446,492
2017-11-15 Richard Stark (SVP, GM - Oncology) Option Ex 27,409 11.28 309,036
2017-07-25 Meteny Dennis S Option Ex 14,000 15.75 220,500
2017-07-25 Johnson Wesley Option Ex 14,000 15.75 220,500
2017-07-25 Gold Jeffrey Option Ex 14,000 15.75 220,500
2017-07-24 Reed Jan Stern Buy 316 16.00 5,056
2017-07-21 Clemmer James C (President and CEO) Buy 5,000 15.79 78,950
2017-07-21 Donnelly Howard W Buy 5,000 15.72 78,600
2017-07-20 Clemmer James C (President and CEO) Buy 20,000 15.64 312,800
2017-06-19 Donnelly Howard W Option Ex 14,000 15.75 220,500
2017-04-12 Navilyst Medical Co-invest, Llc (10% Owner) Sale 2,350,000 16.00 37,600,000
2017-04-12 Burgstahler David F (Director) Sale 2,350,000 16.00 37,600,000
2017-01-13 Laporte Steve Option Ex 14,000 15.75 220,500
2016-11-18 Navilyst Medical Co-invest, Llc (10% Owner) Sale 2,091,294 15.68 32,791,489
2016-11-18 Burgstahler David F (Director) Sale 2,091,294 15.68 32,791,489
2016-08-31 Meteny Dennis S Option Ex 12,000 13.29 159,480
2016-08-31 Gold Jeffrey Option Ex 12,000 13.29 159,480
2016-08-05 Navilyst Medical Co-invest, Llc (10% Owner) Sale 2,241,000 14.62 32,763,420
2016-08-05 Burgstahler David F (Director) Sale 2,250,000 14.62 32,895,000
2016-07-15 Johnson Wesley Option Ex 12,000 13.29 159,480
2016-07-15 Donnelly Howard W Option Ex 12,000 13.29 159,480
2016-07-13 Laporte Steve Option Ex 12,000 13.29 159,480
2016-07-11 Trowbridge Stephen A (SVP and General Counsel) Option Ex 4,576 .00 0
2016-05-06 Greiner Charles R (VP - Global Franchise) Sale 3,508 12.31 43,183
2016-04-25 Trowbridge Stephen A (SVP and General Counsel) Sale 2,440 12.18 29,719
2016-04-21 Trowbridge Stephen A (SVP and General Counsel) Sale 10,500 12.33 129,465
2015-08-05 Trowbridge Stephen A (SVP and General Counsel) Option Ex 5,800 15.27 88,566
2015-08-05 Greiner Charles R (VP - Global Franchise) Option Ex 14,100 15.27 215,307
2015-08-05 Laporte Steve Option Ex 6,000 15.27 91,620
2015-08-05 Meteny Dennis S Option Ex 6,000 15.27 91,620
2015-08-05 Johnson Wesley Option Ex 6,000 15.27 91,620
2015-08-05 Gold Jeffrey Option Ex 6,000 15.27 91,620
2015-07-16 Donnelly Howard W Option Ex 6,000 15.27 91,620
2015-06-08 Johnson Wesley Option Ex 4,649 16.55 76,940
2015-02-13 Richard Stark (SVP, GM - Oncology) Sale 18,100 18.53 335,393
2015-02-13 Richard Stark (SVP, GM - Oncology) Option Ex 18,100 15.27 276,387
2014-10-20 Greiner Charles R (VP - Global Franchise) Sale 3,298 15.63 51,547
2014-07-07 Gold Jeffrey Option Ex 6,000 13.18 79,080
2014-04-14 Kapusta Matthew C (SVP, Business Development) Buy 1,000 13.90 13,900
2014-04-14 Meteny Dennis S Option Ex 15,500 11.00 170,500
2013-11-14 Greiner Charles R (VP - Global Finance) Sale 4,373 15.46 67,610
2013-11-14 Greiner Charles R (VP - Global Finance) Option Ex 4,373 13.18 57,636
2013-11-13 Greiner Charles R (VP - Global Finance) Sale 2,392 15.40 36,841
2013-10-18 Bucci Vincent Buy 5,000 15.20 75,990
2013-10-17 Donnelly Howard W Sale 20,000 15.06 301,200
2013-10-17 Donnelly Howard W Option Ex 20,000 11.00 220,000
2013-07-22 Gould Kevin J Buy 2,700 12.00 32,400
2013-05-09 Greiner Charles R (VP - Global Franchise) Sale 1,495 10.38 15,518
2013-03-25 Gold Jeffrey Option Ex 2,508 6.52 16,357
2013-03-12 Meteny Dennis S Buy 4,600 10.82 49,772
2013-03-12 Bucci Vincent Buy 85,000 10.78 916,300
2013-02-14 Bucci Vincent Buy 2,000 12.17 24,332
2013-01-11 Gould Kevin J Buy 2,700 11.58 31,276
2012-11-05 Richard Stark (SVP, GM - Oncology) Sale 3,160 10.36 32,737
2012-11-05 Gold Jeffrey Buy 1,000 10.56 10,560
2012-07-17 Devivo Joseph (President and CEO) Buy 2,000 11.67 23,340
2012-05-16 Richard Stark (SVP, GM - Oncology) Sale 2,080 12.42 25,827
2012-04-25 Gold Jeffrey Option Ex 418 6.52 2,726
2012-04-23 Echenberg Paul S Option Ex 2,091 6.52 13,637
2012-04-12 Bucci Vincent Buy 4,000 11.82 47,280
2012-04-11 Gould Kevin J Buy 2,700 11.72 31,635
2012-04-10 Kapusta Matthew C (SVP, Business Development) Buy 1,000 11.40 11,397
2012-04-09 Devivo Joseph (President and CEO) Buy 5,000 11.82 59,095
2012-04-09 Bucci Vincent Buy 2,000 11.80 23,596
2012-02-21 Bucci Vincent Buy 2,000 13.44 26,878
2012-02-15 Bucci Vincent Buy 2,000 13.25 26,494
2012-02-13 Devivo Joseph (President and CEO) Buy 3,000 12.95 38,850
2012-02-13 Bucci Vincent Buy 1,000 12.93 12,927
2011-11-16 Devivo Joseph (President and CEO) Buy 2,500 14.14 35,362
2011-09-06 Gersuk D Joseph (EVP - CFO) Option Ex 3,000 13.49 40,470
2011-08-31 Meteny Dennis S Option Ex 5,000 11.00 55,000
2011-08-16 Bucci Vincent Buy 6,000 14.03 84,168
2011-06-01 Echenberg Paul S Option Ex 2,091 4.35 9,091
2010-10-19 Laporte Steve (Director) Buy 1,000 14.29 14,286
2010-09-07 Mapes Harold (VP - Operations) Option Ex 1,250 15.23 19,037
2010-09-07 Appling William M (Vice-President - Research) Option Ex 2,250 15.23 34,267
2010-09-07 Gersuk D Joseph (EVP - CFO) Option Ex 3,000 15.23 45,690
2010-08-17 Mccarthy Shawn P (SVP - General Manager) Option Ex 3,750 .00 0
2010-07-20 Laporte Steve (Director) Buy 500 14.69 7,347
2010-04-27 Echenberg Paul S (Director) Option Ex 2,091 4.35 9,091
2010-04-07 Laporte Steve (Director) Buy 500 15.52 7,760
2010-02-12 Laporte Steve (Director) Buy 500 16.35 8,177
2010-02-05 Johnson Wesley (Director) Buy 4,000 15.81 63,240
2009-07-22 Laporte Steve (Director) Buy 2,000 11.42 22,846
2009-07-22 Donnelly Howard W (Director) Buy 2,000 11.50 23,000
2009-07-21 Keltjens Jan (President & CEO) Buy 5,000 11.25 56,250
2009-05-01 Echenberg Paul S (Director) Option Ex 2,091 4.35 9,091
2009-04-17 Orsatti Charles Thomas (Director) Buy 2,000 12.00 24,000
2009-04-09 Keltjens Jan (President & CEO) Buy 5,000 12.47 62,330
2009-02-23 Meteny Dennis S (Director) Option Ex 3,500 11.00 38,500
2009-02-13 Hobbs Eamonn P (President & CEO) Sale 15,000 12.98 194,775
2009-02-11 Keltjens Jan (President & CEO) Buy 5,000 13.00 65,000
2009-02-06 Bucci Vincent (Director) Option Ex 3,767 5.80 21,848
2009-01-27 Johnson Wesley (Director) Buy 2,426 13.89 33,697
2009-01-23 Donnelly Howard W (Director) Buy 3,000 11.84 35,511
2009-01-09 Laporte Steve (Director) Buy 2,000 12.00 24,000
2008-08-05 Laporte Steve (Director) Buy 1,000 15.92 15,920
2008-05-15 Laporte Steve (Director) Buy 1,300 15.13 19,666
2008-04-16 Hobbs Eamonn P (President & CEO) Buy 2,715 12.97 35,205
2008-03-03 Donnelly Howard W (Director) Option Ex 2,000 11.00 22,000
2007-08-09 Shea Paul J (VP - Sales) Sale 5,100 20.64 105,253
2007-08-09 Shea Paul J (VP - Sales) Option Ex 5,100 13.18 67,218
2007-05-29 Echenberg Paul S (Director) Option Ex 391 9.80 3,831
2007-05-03 Appling William M (Vice-President - Research) Option Ex 2,500 13.18 32,950
2007-04-04 Gerardi Joseph G (Vice President - CFO) Option Ex 1,000 13.18 13,180
2007-03-30 Hobbs Eamonn P (President & CEO) Option Ex 8,364 4.35 36,358
2007-01-25 Echenberg Paul S (Director) Option Ex 78,409 4.35 340,843
2007-01-22 Flaherty Robert E (Director) Option Ex 2,500 11.00 27,500
2007-01-16 Recinella Daniel (VP - Product Development) Sale 3,455 25.00 86,375
2007-01-16 Recinella Daniel (VP - Product Development) Option Ex 3,455 4.35 15,018
2007-01-10 Hobbs Eamonn P (President & CEO) Buy 1,000 24.48 24,480
2006-12-20 Stern Linda B (10% Owner) Option Ex 185,546 14.96 2,776,138
2006-11-28 Stern Linda B (10% Owner) Sale 2,750 21.55 59,254
2006-11-17 Stern Linda B (10% Owner) Sale 2,750 21.15 58,162
2006-11-13 Stern Linda B (10% Owner) Sale 2,750 20.19 55,525
2006-11-09 Stern Linda B (10% Owner) Sale 2,750 20.87 57,389
2006-11-01 Hobbs Eamonn P (President & CEO) Sale 4,082 21.62 88,265
2006-11-01 Hobbs Eamonn P (President & CEO) Option Ex 4,082 4.35 17,744
2006-10-25 Graham Peter J (Director) Option Ex 1,539 2.57 3,950
2006-10-24 Stern Linda B (10% Owner) Sale 2,750 22.93 63,068
2006-10-17 Stern Linda B (10% Owner) Sale 2,750 23.56 64,792
2006-10-16 Echenberg Paul S (Director) Option Ex 2,748 3.55 9,744
2006-10-09 Stern Linda B (10% Owner) Sale 2,750 22.89 62,936
2006-10-03 Stern Linda B (10% Owner) Sale 2,750 21.02 57,807
2006-10-02 Hobbs Eamonn P (President & CEO) Sale 15,000 20.73 310,965
2006-10-02 Hobbs Eamonn P (President & CEO) Option Ex 15,000 4.35 65,205
2006-09-26 Stern Linda B (10% Owner) Sale 2,750 21.32 58,616
2006-09-26 Hobbs Eamonn P (President & CEO) Sale 15,000 21.11 316,590
2006-09-26 Hobbs Eamonn P (President & CEO) Option Ex 15,000 4.35 65,205
2006-09-22 Stern Linda B (10% Owner) Sale 2,750 18.28 50,259
2006-09-20 Stern Linda B (10% Owner) Sale 2,750 18.28 50,259
2006-09-20 Gold Jeffrey (Director) Option Ex 4,600 5.43 24,996
2006-09-13 Stern Linda B (10% Owner) Sale 2,750 16.14 44,374
2006-09-11 Hobbs Eamonn P (President & CEO) Option Ex 10,000 4.35 43,470
2006-08-29 Meteny Dennis S (Director) Option Ex 1,000 11.00 11,000
2006-08-25 Gerardi Joseph G (Vice President - CFO) Option Ex 1,000 13.18 13,180
2006-08-24 Stern Linda B (10% Owner) Sale 2,750 16.99 46,719
2006-08-16 Stern Linda B (10% Owner) Sale 2,750 18.29 50,303
2006-08-11 Hobbs Eamonn P (President & CEO) Option Ex 20,000 4.35 86,940
2006-08-10 Stern Linda B (10% Owner) Sale 2,750 21.77 59,872
2006-08-07 Stern Linda B (10% Owner) Sale 2,750 23.94 65,837
2006-08-01 Hobbs Eamonn P (President & CEO) Sale 10,000 21.94 219,400
2006-08-01 Hobbs Eamonn P (President & CEO) Option Ex 10,000 4.35 43,470
2006-07-28 Stern Linda B (10% Owner) Sale 3,750 23.43 87,847
2006-07-24 Stern Linda B (10% Owner) Sale 7,500 24.07 180,540
2006-07-20 Stern Linda B (10% Owner) Sale 3,750 24.31 91,166
2006-07-18 Stern Linda B (10% Owner) Sale 3,750 23.99 89,966
2006-07-17 Stern Linda B (10% Owner) Sale 3,750 24.26 90,986
2006-07-11 Stern Linda B (10% Owner) Sale 3,750 25.92 97,207
 1   2 

Insider trading activities including stock purchases, stock sales, and option exercises of ANGO listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Angiodynamics Inc (symbol ANGO, CIK number 1275187) see the Securities and Exchange Commission (SEC) website.